{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:42:37Z","timestamp":1792593757809,"version":"4.5.0"},"reference-count":20,"publisher":"MyJove Corporation","issue":"225","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68912","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:02:11Z","timestamp":1763164931000},"source":"Crossref","is-referenced-by-count":1,"title":["Establishment and Maintenance of Patient-derived Prostate Cancer Organoids: A Detailed Experimental Protocol"],"prefix":"10.3791","author":[{"given":"Danyan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"10437","key":"ref1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","type":"journal-article","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","unstructured":"James, N. D. et al. The lancet commission on prostate cancer: planning for the surge in cases. Lancet. 403 (10437), 1683-1722 (2024).","journal-title":"Lancet"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1038\/s41467-024-54847-1","type":"journal-article","article-title":"AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients","volume":"15","author":"Knutson","year":"2024","unstructured":"Knutson, T. P. et al. AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. Nat Commun. 15 (1), 10648 (2024).","journal-title":"Nat Commun"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1078-0432.CCR-24-2061","type":"journal-article","article-title":"Framework for the pathology workup of metastatic castration-resistant prostate cancer biopsies","volume":"31","author":"Haffner","year":"2025","unstructured":"Haffner, M. C. et al. Framework for the pathology workup of metastatic castration-resistant prostate cancer biopsies. Clin Cancer Res. 31 (3), 466-478 (2025).","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40164-023-00433-y","type":"journal-article","article-title":"The role of organoids in cancer research","volume":"12","author":"Fang","year":"2023","unstructured":"Fang, Z., Li, P., Du, F., Shang, L., Li, L. The role of organoids in cancer research. Exp Hematol Oncol. 12 (1), 69 (2023).","journal-title":"Exp Hematol Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","type":"journal-article","article-title":"Organoid cultures for the analysis of cancer phenotypes","volume":"24","author":"Sachs","year":"2014","unstructured":"Sachs, N., Clevers, H. Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev. 24, 68-73 (2014).","journal-title":"Curr Opin Genet Dev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"736431","DOI":"10.3389\/fonc.2021.736431","type":"journal-article","article-title":"Application of organoid models in prostate cancer research","volume":"11","author":"Zhou","year":"2021","unstructured":"Zhou, L., Zhang, C., Zhang, Y., Shi, C. Application of organoid models in prostate cancer research. Front Oncol. 11, 736431 (2021).","journal-title":"Front Oncol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","type":"journal-article","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","unstructured":"Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 159 (1), 176-187 (2014).","journal-title":"Cell"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","type":"journal-article","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","unstructured":"Drost, J. et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc. 11 (2), 347-358 (2016).","journal-title":"Nat Protoc"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","type":"journal-article","article-title":"Patient-derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","unstructured":"Puca, L. et al. Patient-derived organoids to model rare prostate cancer phenotypes. Nat Commun. 9 (1), 2404 (2018).","journal-title":"Nat Commun"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-021-01426-3","type":"journal-article","article-title":"Patient-derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine","volume":"20","author":"Pamarthy","year":"2021","unstructured":"Pamarthy, S., Sabaawy, H. E. Patient-derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine. Mol Cancer. 20 (1), 125 (2021).","journal-title":"Mol Cancer"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41467-021-21300-6","type":"journal-article","article-title":"Patient-derived xenografts and organoids model therapy response in prostate cancer","volume":"12","author":"Karkampouna","year":"2021","unstructured":"Karkampouna, S. et al. Patient-derived xenografts and organoids model therapy response in prostate cancer. Nat Commun. 12 (1), 1117 (2021).","journal-title":"Nat Commun"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","type":"journal-article","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","unstructured":"Driehuis, E., Kretzschmar, K., Clevers, H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 15 (10), 3380-3409 (2020).","journal-title":"Nat Protoc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-pathol-012615-044249","type":"journal-article","article-title":"Organoids as models for neoplastic transformation","volume":"11","author":"Neal","year":"2016","unstructured":"Neal, J. T., Kuo, C. J. Organoids as models for neoplastic transformation. Annu Rev Pathol. 11, 199-220 (2016).","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021093","type":"journal-article","article-title":"Organoids: an emerging precision medicine model for prostate cancer research","volume":"25","author":"Waseem","year":"2024","unstructured":"Waseem, M., Wang, B. D. Organoids: an emerging precision medicine model for prostate cancer research. Int J Mol Sci. 25 (2), (2024).","journal-title":"Int J Mol Sci"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1590\/s1677-5538.ibju.2022.99.04","type":"journal-article","article-title":"Neurovascular bundle preservation in robotic-assisted radical prostatectomy: how I do it after 15,000 cases","volume":"48","author":"Moschovas","year":"2022","unstructured":"Moschovas, M. C., Patel, V. Neurovascular bundle preservation in robotic-assisted radical prostatectomy: how I do it after 15,000 cases. Int Braz J Urol. 48 (2), 212-219 (2022).","journal-title":"Int Braz J Urol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12951-024-03086-z","type":"journal-article","article-title":"Organoid development and applications in gynecological cancers: the new stage of tumor treatment","volume":"23","author":"Li","year":"2025","unstructured":"Li, Y., Qin, M., Liu, N., Zhang, C. Organoid development and applications in gynecological cancers: the new stage of tumor treatment. J Nanobiotechnology. 23 (1), 20 (2025).","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.7150\/thno.96027","type":"journal-article","article-title":"Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development","volume":"14","author":"Xiang","year":"2024","unstructured":"Xiang, D. et al. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development. Theranostics. 14 (8), 3300-3316 (2024).","journal-title":"Theranostics"},{"issue":"22","key":"ref18","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3390\/cells11223632","type":"journal-article","article-title":"Patient-derived xenografts and organoids recapitulate castration-resistant prostate cancer with sustained androgen receptor signaling","volume":"11","author":"Van Hemelryk","year":"2022","unstructured":"Van Hemelryk, A. et al. Patient-derived xenografts and organoids recapitulate castration-resistant prostate cancer with sustained androgen receptor signaling. Cells. 11 (22), 3632 (2022).","journal-title":"Cells"},{"issue":"13","key":"ref19","doi-asserted-by":"crossref","first-page":"e2414558","DOI":"10.1002\/advs.202414558","type":"journal-article","article-title":"Patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment","volume":"12","author":"Zhao","year":"2025","unstructured":"Zhao, H. et al. Patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment. Adv Sci (Weinh). 12 (13), e2414558 (2025).","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","type":"journal-article","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","unstructured":"Polak, R., Zhang, E. T., Kuo, C. J. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 24 (8), 523-539 (2024).","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68912\/establishment-maintenance-patient-derived-prostate-cancer-organoids","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:10Z","timestamp":1792591990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68912\/establishment-maintenance-patient-derived-prostate-cancer-organoids"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":20,"journal-issue":{"issue":"225","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68912","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}